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Abstract
Background—Prenatal polybrominated diphenyl ether (PBDE) exposure has been associated 
with decrements in IQ and increased attention deficit/hyperactivity disorder related behaviors in 
children; however, data are limited for the role of postnatal exposures.
Objectives—We investigated the association between a series of childhood PBDE concentrations 
and Full-Scale Intelligence Quotient (FSIQ) and externalizing problems at 8 years.
Methods—We used data from 208 children in the Health Outcomes and Measures of the 
Environment (HOME) Study, a prospective pregnancy and birth cohort. Child serum PBDEs were 
measured at 1, 2, 3, 5, and 8 years; missing serum PBDE concentrations were estimated via 
multiple imputation. The Wechsler Intelligence Scales for Children-IV and the Behavior 
Assessment System for Children-2 was used to assess intelligence and externalizing behavior, 
respectively, in children at 8 years. We used multiple informant models to estimate associations 
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between repeated lipid-adjusted PBDEs and child neurobehavior and to test for windows of 
susceptibility.
Results—Postnatal exposure to PBDE congeners (-28, -47, -99, -100, and -153) at multiple ages 
was inversely associated with FSIQ at 8 years. For instance, a 10-fold increase in BDE-153 
concentrations at 2, 3, 5, and 8 years were all related to lower FSIQ at age 8 (β for 3 years: −7.7-
points, 95% CI −12.5, −2.9; β for 8 years: −5.6-points, 95% CI −10.8, −0.4). Multiple PBDE 
congeners at 8 years were associated with increased hyperactivity and aggressive behaviors at 8 
years.
Conclusions—Postnatal PBDE exposure was associated with decrements in FSIQ and increases 
in hyperactivity and aggressive behaviors.
Keywords
Polybrominated diphenyl ether (PBDE); neurobehavior; postnatal; intelligence; externalizing 
behavior
1. Introduction
Commercial mixtures of polybrominated diphenyl ethers (PBDEs) were used extensively for 
decades as additive flame retardants in a multitude of consumer products, including 
polyurethane foams, carpet padding, furniture, and electronic devices to reduce fire 
incidence and the related economic costs. While PBDEs have been removed from the U.S. 
market, they remain ubiquitous environmental contaminants with detectable levels in air, 
dust, soil, wildlife, as well as in human biospecimens (Costa and Giordano, 2007). Infants 
and children have several fold higher serum PBDE concentrations on a lipid basis than 
adults due to placental and lactational transfers and child-specific behaviors, such as 
frequent hand-to-mouth actions and crawling on the floor (Schecter et al., 2005; Toms et al., 
2008; Toms et al., 2009).
Evidence from several epidemiological studies indicates that PBDEs are neurotoxic when 
exposure occurs during fetal development, with reports of decrements in Full Scale IQ 
(FSIQ), impaired executive function, lower reading and language abilities, and increased 
attention deficit/hyperactivity disorder (ADHD) related behaviors (Chen et al., 2014; Cowell 
et al., 2015; Ding et al., 2015; Eskenazi et al., 2013; Herbstman et al., 2010; Shy et al., 2011; 
Vuong et al., 2016; Zhang et al., 2016). Postulated mechanisms by which PBDEs may exert 
neurotoxic effects include indirectly affecting brain development through thyroid hormone 
disruption or directly acting on brain cells by causing oxidative stress, interfering with signal 
transduction, altering cholinergic system responses, inducing neuronal apoptosis, and 
altering neurotransmitter release and function (Costa et al., 2014; Costa and Giordano, 2011; 
Dingemans et al., 2011).
PBDEs may continue to adversely affect neurobehavioral domains even after birth as rapid 
brain growth continues until two years of age. In addition, neural development, including 
synaptogenesis and myelination, extends through puberty (Rice and Barone, 2000). 
However, it is uncertain whether childhood PBDE exposures are adversely associated with 
neurobehavior, as few studies have examined early childhood as a vulnerable window of 
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susceptibility to PBDE neurotoxicity. Only four papers have investigated childhood serum 
PBDEs and neurobehavior; half observed adverse associations with FSIQ and ADHD-
related behaviors (Eskenazi et al., 2013; Gascon et al., 2011; Przybyla et al., 2016; Sagiv et 
al., 2015). Given that PBDE concentrations are higher in children than the developing fetus 
and the lack of studies that identified windows of susceptibility for PBDE neurotoxicity in 
childhood, we examined the association between childhood PBDEs measured at 1–8 years 
and FSIQ and externalizing behaviors at 8 years.
2. Methods
2.1 Study Participants and Design
The study consisted of participants enrolled in the Health Outcomes and Measures of the 
Environment (HOME) Study, an ongoing prospective pregnancy and birth cohort established 
in the Greater Cincinnati area (Ohio, USA). Detailed information on enrollment, inclusion 
criteria, and neurobehavioral assessments are described by Braun et al. (2016). The HOME 
Study included 390 singleton births at delivery and completed multiple postnatal follow-up 
visits up to age 8 years. The present study included 208 singleton children with at least one 
serum PBDE measure between 1–8 years and a neurobehavior assessment at 8 years. The 
study protocol was approved by the Institutional Review Boards at the Cincinnati Children’s 
Hospital Medical Center and the Centers for Disease Control and Prevention (CDC).
2.2 Childhood serum PBDEs
Concentrations of BDEs-17, -28, -47, -66, -85, -99, -100, -153, -154, -183, and -209 were 
measured in children’s serum samples collected at 1, 2, 3, 5, and 8 years, using gas 
chromatography/isotope dilution high-resolution mass spectrometry (Jones et al., 2012; 
Sjodin et al., 2004). Samples were processed in batches of twenty-four unknown, three 
quality control, and three method blank samples. PBDE concentrations <LOD (limit of 
detection) were substituted with LOD/√2 (Hornung and Reed, 1990). LOD was defined as 
three times the SD of the method blanks or the lowest calibration standard point 0.5 pg/µL 
corresponding to 5 pg per sample (in the absence of detectable blanks). We report PBDE 
concentrations as ng/g serum lipid. Serum lipid concentrations were calculated from 
concentrations of triglycerides and total cholesterol (Phillips et al., 1989). We analyzed 
individual PBDE congeners with detection frequencies ≥80%, which included BDE-28, -47, 
-99, -100, -153, and their sum (ΣPBDEs). Of the 208 children with neurobehavioral 
assessments at 8 years, PBDEs were available for 86 (41%), 69 (33%), 69 (33%), 141 
(68%), and 192 (92%) at ages 1, 2, 3, 5, and 8 years, respectively.
Due to limited serum availability at 1–3 years required to meet the volume needed by the 
assays, PBDEs were unable to be measured in the majority of the children during early 
childhood. Thus, we estimated PBDE concentrations for children who had at least one 
PBDE measurement from 1–8 years, but were missing concentrations at other time points 
via multiple imputation using the Markov Chain Monte Carlo (MCMC) method, in which 
100 imputations were produced (Bodner, 2008). This provides a set of 100 plausible PBDE 
estimates that also incorporates the uncertainty or error associated with the missing data 
(Rubin, 1987). Auxiliary variables in the imputation models were selected based on their 
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correlation with childhood PBDEs (p<0.05) and included maternal blood lead concentrations 
during pregnancy, household income, marital status, whether the child was breastfed, and 
Home Observation for Measurement of the Environment (HOME) Score. Maternal serum 
polychlorinated biphenyls (ΣPCBs) of 15 congeners during pregnancy were added to the 
imputation model due to its correlation with PBDEs at 2 years (p=0.02). Both log10-
transformed prenatal and postnatal PBDEs were included, because of their long half-life and 
consideration of placental and lactational transfers (Toms et al., 2009). Lastly, FSIQ at 8 
years was included as excluding the dependent variable would cause estimated associations 
to be biased toward the null (Enders, 2010). Convergence of imputation models were 
assessed using trace and auto-correlation plots.
2.3 Neurobehavior Assessments
Trained HOME Study staff, certified by a developmental psychologist, administered the 
Wechsler Intelligence Scale for Children-IV (WISC-IV) to children at age 8 years to 
measure FSIQ (Wechsler, 2003; Wechsler, 2004). To assess adaptive and behavioral 
problems in children, parents were requested to complete the Behavioral Assessment System 
for Children-2 (BASC-2) (Reynolds and Kamphaus, 2004). We focused on FSIQ and 
Externalizing Problems and its subscales (hyperactivity, aggression, conduct disorder), 
because prenatal PBDEs were significantly associated with FSIQ deficits and increased 
externalizing behavior in several epidemiologic studies (Chen et al., 2014; Cowell et al., 
2015; Eskenazi et al., 2013; Roze et al., 2009; Zhang et al., 2016). The BASC-2 has a 
population mean of 50±10, with higher scores indicating increased problem behaviors. 
Neither HOME Study staff nor parents had knowledge of prenatal or childhood PBDE 
concentrations at the neurobehavioral assessment.
2.4 Statistical analyses
We investigated associations between log10-transformed child serum PBDEs and FSIQ and 
Externalizing Problems at 8 years with multiple informant models (Horton et al., 1999; 
Litman et al., 2007), which are non-standard versions of generalized estimating equations 
that allow for repeated environmental chemical measurements (Sanchez et al., 2011). This 
method allows us to identify windows of susceptibility for PBDE neurotoxicity by including 
interaction terms between child age and PBDE concentrations. We estimated βs and 95% 
confidence intervals (CIs) for BDE-28, -47, -99, -100, -153, and ΣPBDEs with separate 
multiple informant models for each of the 100 imputed datasets. Final estimates for PBDEs 
were an average of the 100 results from imputed datasets (Beunckens et al., 2008; Shen and 
Chen, 2013) and are presented for ages 1, 2, 3, 5, and 8 years, because several interaction 
terms between PBDEs (continuous) and age (categorical) were statistically significant 
(p<0.10).
Covariates in the final models, selected based on their relationship with FSIQ or 
Externalizing Problems (p<0.10), included maternal age, race/ethnicity, household income, 
maternal serum cotinine at 16±3 weeks (ng/mL, continuous), marital status, maternal IQ 
(continuous, assessed by Wechsler Abbreviated Scale of Intelligence) (Wechsler, 1999), 
maternal depression (assessed by Beck Depression Inventory II at enrollment) (Beck et al., 
1996), HOME inventory score at the 1-year home visit (Caldwell and Bradley, 1984), and 
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child sex. Effect measure modification by child sex was examined using interaction terms 
between PBDEs (continuous), child sex (categorical), and child age (categorical), as well as 
all 2-way interactions (p<0.10).
In a sensitivity analysis, we performed non-imputation-based modeling to determine 
whether results differ between imputation-based and non-imputation-based models. We ran 
multiple informant models, as described above, using the original, non-imputed data to 
examine associations between childhood PBDEs and FSIQ and externalizing behaviors in 
children at 8 years. We also wanted to determine whether overall conclusions would differ 
had we used a traditional modeling method rather than multiple informant models. Using the 
original, non-imputed data, we performed separate multiple linear regression models to 
estimate βs and 95% CIs for individual PBDE congeners and ΣPBDEs measured during 
childhood in relation to our outcomes at 8 years. In another sensitivity analysis, we added 
blood lead levels at 8 years as a covariate to determine whether results are similar after 
adjustment for this known neurotoxicant. While peak exposure levels for lead occur at 18–30 
months in the US, studies have reported that concurrent blood lead levels are associated with 
decreased IQ points (Chen et al., 2005; Lanphear et al., 2005). We also performed an 
adjustment for prenatal PBDEs, which have been found to neurotoxic in previous 
epidemiologic studies, and breastfeeding duration (months).
3. Results
3.1 PBDE concentrations
The geometric mean (GM) of PBDEs at 2 and 3 years in the imputed datasets were slightly 
higher than the original dataset, while concentrations at 1, 5, and 8 years were more 
comparable to the original dataset (see Table S1). Imputed ΣPBDE concentrations in the 
datasets peaked at 2 years (127.7±2.5 ng/g lipid) and gradually decreased as children aged 
(Table 1). The most abundant congener was BDE-47, with GMs of 58.5±2.6, 66.2±2.9, 
47.3±2.8, 30.8±2.6, and 20.3±2.5 ng/g lipid at 1, 2, 3, 5, and 8 years, respectively (see Table 
S1). PBDE congeners were positively correlated with each other during childhood, with high 
correlation coefficients at 1 year (rp=0.64–0.95, p<0.0001), 2 years (rp=0.60–0.95, 
p<0.0001), 3 years (rp=0.48–0.97, p<0.001), 5 years (rp=0.49–0.95, p<0.0001), and 8 years 
(rp=0.43–0.94, p<0.0001) (see Table S2).
3.2 Participant characteristics
Overall, childhood ΣPBDEs were significantly higher among children whose mothers 
identified as non-Hispanic black or other race/ethnicities, were younger, were experiencing 
moderate to severe depression, and were single or living alone. Children from homes with a 
household income <$40,000 and who had lower HOME scores were more likely to have 
higher ΣPBDE concentrations. Child FSIQ at age 8 years was higher among those with 
mothers who were older, non-Hispanic white, of higher income, married/living with a 
partner, minimally/mildly depressed, and who had a higher HOME score. Scores for 
Externalizing Problems were significantly higher in males and children of mothers 
experiencing moderate to severe depression. Children included in our study (n=208) were 
more likely to have mothers who were not married or living alone than those excluded due to 
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loss of follow-up, inability to complete a blood draw, or missing neurobehavioral 
assessments at age 8 years (n=182) (see Table S3). However, children excluded from the 
present study due to missing information were comparable on all other sociodemographic 
characteristics, maternal characteristics (e.g., depression, IQ), home environment, and child 
sex. Maternal IQ was inversely correlated with ΣPBDEs at 2 and 3 years and positively 
correlated with child FSIQ (Table 2). Maternal serum cotinine was positively correlated with 
ΣPBDEs at 2 and 3 years and inversely correlated with child FSIQ.
3.3 Postnatal PBDEs and FSIQ
We observed an overall pattern of an inverse association between log10-transformed 
childhood PBDEs and FSIQ at age 8 years (Figure 1). A 10-fold increase in BDE-28 at 3 
years was associated with a 7.9-point decrease (95% CI: −13.6, −2.3) in FSIQ. Ten-fold 
higher BDE-153 at ages 2, 3, 5, and 8 years were significantly associated with FSIQ 
decrements of 5.4-points (95% CI: −10.8, −0.1), 7.7-points (95% CI: −12.5, −2.9), 8.2-
points (95% CI: −13.4, −3.0), and 5.6-points (95% CI: −10.8, −0.4), respectively. Ten-fold 
ΣPBDE increases at ages 3 and 5 years were associated with lower FSIQ at 8 years (β=−4.8, 
95% CI: −10.2, 0.5 and β=−4.5, 95% CI: −9.6, 0.6, respectively), with borderline 
significance (p<0.10).
3.4 Postnatal PBDEs and externalizing behaviors
Several PBDE congeners at 8 years were associated with higher concurrent Externalizing 
Problems scores, including BDE-28 (β=4.7, 95% CI: 0.8, 8.6), BDE-47 (β=3.4, 95% CI: 
0.004, 6.8), BDE-153 (β=4.2, 95% CI: 0.4, 8.0), and ΣPBDEs (β=4.3, 95% CI: 0.4, 8.2); 
estimates were all for a 10-fold concentration increase (Figure 2). Hyperactivity and 
Aggression scores were higher among children with increased PBDE concentrations at age 8 
years, with statistical significance for BDE-28 and -153 in relation to Hyperactivity and 
BDE-28, -47, -99, and ΣPBDEs in relation to Aggression. For earlier ages of PBDE 
exposures, only BDE-153 at 1 year was associated with Externalizing Problems (β=3.7, 95% 
CI: 0.1, 7.2) and Aggression (β=3.4, 95% CI: 0.1, 6.8). We did not observe any association 
between childhood PBDEs and Conduct Disorder scores (results not shown).
3.5 Child sex differences
We observed effect modification by child sex between several PBDE congeners at 8 years 
and FSIQ (see Table S4). Concurrent BDE-47 and ΣPBDEs were associated with lower 
FSIQ scores in males (β=−5.6, 95% CI: −11.0, −0.2 and β=−7.4, 95% CI: −13.2, −1.6), but 
no associations in females. This pattern was also noted with BDE-99 and -100 at 8 years. 
For Externalizing Problems, a 10-fold increase in BDE-153 at 8 years was associated with a 
7.2-point increase (95% CI: 2.9, 11.5) in males, but no associations in females.
3.6 Sensitivity analyses
Results from our non-imputation-based multiple informant models were similar to findings 
from imputation-based analyses despite a smaller sample size. Significant decreases in FSIQ 
were observed with 10-fold increases in BDE-28 at 3 years (β=−12.3, 95% CI: −23.6, −1.1) 
and BDE-153 at 5 years (β=−8.1, 95% CI: −14.0, −2.2) in our non-imputation-based 
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modeling (Table 3). Several PBDEs at 8 years remained positively associated with 
externalizing behaviors, hyperactivity, and aggression. In addition, linear regression models 
using the original, non-imputed data yielded similar results, with statistically significant 
positive associations noted between concurrent PBDEs and externalizing behaviors, 
hyperactivity, and aggression (see Table S5). Decrements in FSIQ were again observed with 
increased BDE-153 concentrations at 5 years. However, previous inverse associations 
between BDE-153 at other years during childhood as well as BDE-28 at 3 years failed to 
reach statistical significance. Lastly, adjusting for blood lead at age 8 years, prenatal PBDEs, 
and breastfeeding duration did not appreciably change our results (results not shown).
4. Discussion
Our findings suggest that childhood PBDEs are associated with lower FSIQ in children. 
Specifically, each 10-fold increase in BDE-28 at 3 years and BDE-153 at 2–8 years were 
significantly associated with >5-point decrements in FSIQ at 8 years. Our results align with 
findings from the U.S. CHAMACOS (Center for the Health Assessment of Mothers and 
Children of Salinas) Study that examined PBDEs and FSIQ, both assessed at 7 years of age 
(−5.6-point decrease [95% CI: −10.8, −0.3] with a 10-fold increase in Σ4PBDEs [BDEs 47, 
99, 100, and 153]) (Eskenazi et al., 2013). However, null associations were reported between 
4-year BDE-47 and cognition scores in a cohort in Menorca, Spain (Gascon et al., 2011). No 
other study outside of these has examined child serum PBDEs and FSIQ. Studies examining 
PBDEs in breastmilk and cognition have yielded conflicting results. In a Taiwanese study, 
Σ14PBDEs in breastmilk was not correlated with scores on cognition or language at 8–12 
months (Chao et al., 2011). In contrast, improvements in cognition were reported in children 
at 36 months with higher breastmilk BDE-153 in the North Carolina PIN (Pregnancy, 
Infection, and Nutrition) Babies Study (Adgent et al., 2014).
We found consistent evidence suggesting PBDE concentrations at age 8 years were 
associated with externalizing behaviors measured concurrently, including hyperactivity and 
aggression. Further, increased risk of having a score ≥60 in Hyperactivity or Aggression was 
also observed with higher BDE-28, -47, -153, and ΣPBDEs. Previously, BDE-47, -99, and 
-100 concentrations in breastmilk were associated with increased externalizing behaviors at 
30 months of age (Hoffman et al., 2012). Findings from our study also corroborate those of 
the CHAMACOS Study, which reported increased attention and hyperactivity problems in 
children with higher Σ4PBDEs concentrations at 7 years (Eskenazi et al., 2013). However, 
null associations were reported within the same cohort between Σ4PBDEs at 9 years and 
hyperactivity and attention problems at 9–12 years, though sex-specific impairments in 
executive function were observed among females (Sagiv et al., 2015). Gascon et al. (2011) 
reported increased risk of attention deficit symptoms at 4 years with higher concurrent 
BDE-47, though no association was observed with hyperactivity. Additionally, no 
association was reported between PBDEs in children 12–15 years and self-reported ADHD 
in the U.S. National Health and Nutrition Examination Survey (NHANES) (Przybyla et al., 
2016).
Epidemiologic studies examining postnatal PBDEs and neurobehavior are limited and 
inconsistent. Contradictory conclusions may be due to the timing and matrices in which 
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PBDEs were quantified. Only three studies measured PBDEs in child serum: CHAMACOS, 
Spain, and the NHANES (Eskenazi et al., 2013; Gascon et al., 2011; Przybyla et al., 2016; 
Sagiv et al., 2015), as we did; while others assessed concentrations in breastmilk, which only 
partially indicate first year exposure levels for breastfed infants without incorporating 
placenta transfer or postnatal dust ingestion (Adgent et al., 2014; Chao et al., 2011; Hoffman 
et al., 2012). Secondly, our study is a prospective birth cohort with multiple prospective 
PBDE measurements, while Gascon et al. (2011) and Przybyla et al.’s (2016) were cross-
sectional. Third, contrasting neurobehavioral domains, neurodevelopmental batteries, and 
age at assessment may also contribute to discordant findings. Only two studies (PIN and 
CHAMACOS) utilized the same assessments we used (WISC-IV, BASC-2) (Adgent et al., 
2014; Eskenazi et al., 2013; Sagiv et al., 2015), and the CHAMACOS Study assessed 
neurobehavior at 7–12 years, whereas Adgent et al. (2014) examined children at 36 months. 
Fourth, PBDE concentrations varied between cohorts. The GM of BDE-47 in HOME Study 
children at age 8 years was 20.3 ng/g lipid, while the CHAMACOS Study had lower 
concentrations at 7 years (15.8 ng/g lipid) and higher concentrations at 9 years (35.2 ng/g 
lipid) (Eskenazi et al., 2013; Sagiv et al., 2015). Further, median serum concentrations of 
BDE-47 at 4 years in the Menorca cohort were very low (0.12 ng/g lipid) (Gascon et al., 
2011).
We did not observe sexually dimorphic relationships for our main findings between PBDEs 
and FSIQ (BDE-28 at 3 years; BDE-153 at 2, 3, 5, and 8 years) and Externalizing Problems 
(BDE-28, -47, and ΣPBDEs at 8 years; BDE-153 at 1 year). Although, effect measure 
modification by child sex was found among associations that were not significant in our 
main analyses (FSIQ: BDE-47, -100, and ΣPBDEs at 8 years), with male-specific deficits in 
FSIQ. While it is unclear whether the associations between childhood PBDEs and FSIQ are 
modified by child sex, Leonetti et al (2016) have reported higher concentrations of PBDEs 
in the placentas of male infants than females. In addition, PBDEs were observed to alter 
thyroid hormone function in a sex-specific manner. However, the CHAMACOS Study 
reported no sex differences between Σ4PBDEs and FSIQ at 7 years (Eskenazi et al., 2013). 
In contrast, Sagiv et al. (2015) observed females in the same cohort were more sensitive to 
Σ4PBDEs at 9 years for attention and hyperactivity at 9–12 years of age. It is possible that 
sexually dimorphic relationships exist between PBDEs and neurobehavior at some 
combination of congeners and age points. However, the main findings from the HOME and 
CHAMACOS Studies suggest postnatal PBDEs are neurotoxic to both sexes.
Our findings provide evidence to support PBDEs’ neurotoxicity during childhood. Deficits 
in FSIQ at age 8 were observed across several PBDE congeners as well as the sum of the 
congeners. We observed statistically significant associations with BDE-153, which is more 
difficult to metabolize and excrete and has a higher fat deposition than other PBDE 
congeners (Staskal et al., 2006). We found that PBDEs at multiple time points during 
childhood were associated with FSIQ decrements at age 8, but most significant associations 
with externalizing behaviors were with concurrent PBDE concentrations at 8 years. It is 
possible that PBDEs are neurotoxic; however, windows of susceptibility may depend on the 
neurodevelopmental domain. Both the CHAMACOS and HOME Study report decrements in 
FSIQ and increased externalizing problems with increased prenatal PBDEs and postnatal 
PBDEs measured in children up to 8 years.
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This study has several methodological strengths, including its prospective study design and 
long follow-up period. We also had comprehensive measures of childhood serum PBDEs at 
multiple time points that allowed us to estimate associations for different exposure windows. 
By utilizing multiple informant models, we were able to conduct a comprehensive 
investigation of childhood PBDEs to identify windows of susceptibility to postnatal PBDE 
neurotoxicity, which has not been done in previous epidemiologic studies. Third, we 
estimated missing PBDEs using multiple imputation to minimize a loss in power. While 
imputing PBDE estimates are likely to result in some degree of random error, multiple 
imputation yielded GMs that were similar to the original, non-imputed PBDE 
measurements, with only slightly higher GMs for PBDEs at 2 and 3 years. In addition, study 
findings did not differ when we only examined non-imputed data, providing further 
assurance of the imputation-based modeling. Further, the main findings from our study were 
between PBDEs at 5 and 8 years and decrements in FSIQ and increased externalizing 
problems. PBDE concentrations were only imputed in 32% and 8% of HOME Study 
children at 5 and 8 years, respectively. Additional analyses examining this research question 
using the original, non-imputed data with a traditional modeling approach of multiple linear 
regression yielded similar conclusions. As such, concerns regarding the study’s findings 
based on imputed data are alleviated. Fourth, PBDE concentrations in the HOME Study are 
similar to levels in other U.S. cohorts (Eskenazi et al., 2013). Further, PBDE concentrations 
in HOME Study mothers (GM=21.7 ng/g lipid) are representative of pregnant women in US 
population (GM=23.9 ng/g lipid) (Woodruff et al., 2011). Lastly, we were able to adjust for 
an extensive array of confounders, including sociodemographics, the home environment, and 
maternal IQ and depressive symptoms.
Nevertheless, our findings are subject to some limitations, including selection bias. However, 
despite sample attrition, children included in the present study were similar to those 
excluded due to missing PBDEs and/or neurobehavior measures with regard to prenatal 
BDE-47 concentrations, sociodemographics, home environment, sex, and maternal 
characteristics (except marital status). Multiple comparisons is also a concern; however, we 
used multiple informant models to incorporate all PBDE measures in the same model, 
thereby reducing the total number of models. Of the 24 models in the present study, we 
would expect to see one statistically significant association based on chance alone. However, 
we observed 10 statistically significant findings. Further, our sensitivity analyses of the 24 
models resulted in 12 statistically significant associations. In addition, we acknowledge that 
separating congener-specific associations is difficult due to the high correlations between 
congeners. Residual confounding by socioeconomic status may also be a concern as effect 
estimates were greatly attenuated by the inclusion of household income. Finally, our study 
cannot address the discrepancies that were observed in the CHAMACOS Study with regard 
to postnatal PBDEs and externalizing behaviors. In that study, despite reporting increased 
hyperactivity problems in children at 7 years with increased concurrent PBDE 
concentrations, non-significant findings were observed between PBDE concentrations at 9 
years and hyperactivity at 9–12 years. These conflicting results may be due to the nonlinear 
continuity of externalizing problems, which decreases from early childhood to 
preadolescence and increases during adolescence before declining once more as adolescents 
reach adulthood (Petersen et al., 2015). Further, the cohort profile of the CHAMACOS 
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Study changed with the second child recruitment wave at age 9 years. The examination of 
childhood PBDEs and attention and executive function were limited to 9 year concentrations 
due to unmeasured PBDE estimates earlier in childhood in the newly enrolled children.
5. Conclusion
These findings suggest that PBDE exposure during childhood may be associated with 
decrements in child IQ and increases in externalizing behaviors. Given that the increases in 
PBDE concentrations after birth coincide with ongoing brain development, it is paramount 
that additional studies examine PBDEs’ potential neurotoxicity during childhood taking into 
account mixtures of multiple environmental pollutants and in adolescence when children are 
encountering academic challenges and new social patterns. Finally, this study highlights the 
need to further reduce exposures to PBDEs in childhood.
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• Childhood PBDEs are associated with decrements in FSIQ at 8 years
• BDE-28 at 3 years and BDE-153 at 2–8 years significantly reduced FSIQ by 
>5 points.
• Several PBDEs at 8 years were positively associated with externalizing 
behaviors
• Concurrent PBDEs were associated with increased hyperactivity and 
aggression scores
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Estimated score differences and 95% CIs in WISC FSIQ at 8 years by a 10-fold increase in 
childhood PBDE concentrations in each exposure window, HOME Study. Adjusted by 
maternal age, race, marital status, maternal serum cotinine, maternal IQ, child sex, maternal 
depression, household income, and HOME Score.
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Estimated score differences and 95% CIs in BASC-2 Externalizing Problems and its 
subscales by a 10-fold increase in childhood PBDE concentrations, HOME Study. Adjusted 
by maternal age, race, marital status, maternal serum cotinine, maternal IQ, child sex, 
maternal depression, household income, and HOME score.
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Table 3
Estimated score differences and 95% CIs in WISC FSIQ and BASC-2 Externalizing Problems and its 
subscales at 8 years by a 10-fold increase in childhood polybrominated diphenyl ether concentrations in the 





β (95% CI) β (95% CI) β (95% CI) β (95% CI)
BDE-28
  1 year 4.0 (−5.7, 13.8) 1.6 (−4.7, 8.0) −0.6 (−7.4, 6.2) 3.8 (−2.6, 10.1)
  2 years −4.2 (−17.8, 9.4) −3.4 (−10.8, 3.9) −6.6 (−13.9, 0.7) −0.6 (−8.8, 7.6)
  3 years −12.3 (−23.6, −1.1) −2.0 (−11.3, 7.2) −3.6 (−12.0, 4.8) −1.2 (−9.0, 6.6)
  5 years −2.4 (−9.5, 4.8) −3.6 (−7.8, 0.5) −4.3 (−9.7, 1.2) −0.9 (−4.5, 2.7)
  8 years −2.3 (−7.8, 3.3) 4.8 (1.6, 8.0) 5.0 (0.8, 9.2) 4.6 (1.4, 7.7)
BDE-47
  1 year −1.5 (−7.3, 4.2) −0.8 (−5.2, 3.6) −2.4 (−6.7, 1.8) 1.4 (−2.7, 5.6)
  2 years −3.9 (−11.7, 3.9) −2.3 (−8.2, 3.5) −3.5 (−9.3, 2.2) 0.2 (−5.8, 6.2)
  3 years −4.7 (−12.6, 3.2) −1.8 (−7.1, 3.5) −2.7 (−8.2, 2.7) 0.2 (−4.9, 5.2)
  5 years −1.6 (−7.4, 4.1) −0.8 (−3.8, 2.3) −1.0 (−4.7, 2.8) 1.4 (−1.6, 4.4)
  8 years −1.3 (−6.5, 3.9) 3.4 (0.2, 6.5) 2.0 (−1.9, 5.8) 4.7 (1.7, 7.7)
BDE-99
  1 year −2.8 (−7.9, 2.3) −0.3 (−4.3, 3.8) −1.3 (−5.1, 2.5) 1.2 (−2.6, 5.0)
  2 years −2.4 (−10.1, 5.2) −1.4 (−6.6, 3.8) −1.7 (−6.6, 3.2) −0.01 (−5.7, 5.7)
  3 years −3.5 (−10.7, 3.7) −1.2 (−5.9, 3.5) −1.4 (−6.2, 3.4) 0.1 (−4.5, 4.6)
  5 years −1.8 (−7.3, 3.7) −0.4 (−3.2, 2.5) −0.6 (−4.0, 2.8) 1.5 (−1.3, 4.3)
  8 years −1.1 (−6.1, 3.8) 2.1 (−1.2, 5.4) 1.0 (−3.0, 4.9) 3.6 (0.5, 6.7)
BDE-100
  1 year −3.0 (−8.9, 3.0) −1.6 (−6.0, 2.8) −2.8 (−7.0, 1.4) 0.3 (−3.7, 4.4)
  2 years −3.6 (−12.0, 4.8) −3.5 (−8.9, 2.0) −3.6 (−8.9, 1.7) −2.0 (−7.9, 4.0)
  3 years −6.3 (−14.7, 2.1) −3.0 (−8.3, 2.4) −3.4 (−8.8, 2.0) 1.4 (−6.6, 3.8)
  5 years −4.5 (−10.4, 1.3) −1.2 (−4.6, 2.1) −0.9 (−4.8, 3.0) 0.7 (−2.6, 4.0)
  8 years −0.8 (−6.5, 4.9) 2.2 (−1.2, 5.7) 1.8 (−2.3, 5.9) 3.2 (−0.2, 6.6)
BDE-153
  1 year −2.8 (−8.2, 2.6) 0.7 (−3.7, 5.1) 0.7 (−3.1, 4.6) 0.9 (−3.0, 4.8)
  2 years −4.1 (−11.5, 3.2) −1.1 (−5.8, 3.5) 0.4 (−3.8, 4.5) −2.1 (−6.9, 2.8)
  3 years −7.1 (−14.4, 0.2) −1.1 (−6.7, 4.6) 0.3 (−4.7, 5.3) −2.0 (−7.4, 3.4)
  5 years −8.1 (−14.0, −2.2) −1.4 (−6.5, 3.6) −0.4 (−5.5, 4.7) 0.1 (−4.8, 5.0)
  8 years −3.8 (−9.4, 1.8) 4.0 (0.2, 7.8) 4.7 (0.7, 8.6) 3.4 (−0.8, 7.6)
ΣPBDEs
  1 year −1.3 (−9.2, 6.6) 0.3 (−5.0, 5.6) −0.7 (−6.2, 4.9) 1.6 (−3.6, 6.8)
  2 years −6.2 (−19.7, 7.4) −3.0 (−8.8, 2.7) −5.0 (−11.0, 1.0) −1.2 (−8.3, 5.9)
  3 years −11.1 (−23.9, 1.6) −1.6 (−10.3, 7.2) −1.3 (−10.3, 7.7) −3.4 (−11.2, 4.3)
  5 years −2.7 (−10.0, 4.7) −1.7 (−5.6, 2.2) −1.7 (−6.7, 3.3) 0.5 (−3.1, 4.0)


















β (95% CI) β (95% CI) β (95% CI) β (95% CI)
  8 years −2.5 (−8.7, 3.7) 3.9 (0.4, 7.5) 2.9 (−1.6, 7.4) 4.9 (1.4, 8.5)
a
Adjusted by maternal age, race/ethnicity, marital status, maternal serum cotinine, maternal IQ, child sex, maternal depression, household income, 
and HOME Score.
b
Externalizing Problems: Hyperactivity + Aggression + Conduct Disorder
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